Coeptis Therapeutics Holdings was hit with a shareholder lawsuit on Jan. 9 in New York Supreme Court for New York County over the company's proposed $835 million merger with Z Squared. The suit, ...
BRISTOL, TN / ACCESS Newswire / January 6, 2026 / The Vanderbilt Report today published coverage of Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) following the company's recent SEC filings ...
WEXFORD, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, , announced today ...
BRISTOL, TN / ACCESS Newswire / October 1, 2025 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) today announced that The Vanderbilt Report has published coverage of the company following its ...
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen technology and biopharmaceutical company, is pleased to ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Wexford's Coeptis Therapeutics ...
COEPTIS, Inc. has announced a strategic partnership with its NexGenAI Affiliates Network and NUBURU, Inc. This collaboration aims to enhance NUBURU's Transformation Plan, which focuses on improving ...
WEXFORD, Pa., Feb. 6, 2025 /PRNewswire/ -- COEPTIS, Inc. (Nasdaq: COEP) (the "Company" or "Coeptis"), a pioneering technology company dedicated to advancing cutting-edge technologies and artificial ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company recently rebranded ...
Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder Value By integrating NexGenAI's advanced tools, COEPTIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results